Olin Corporation
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Olin Corporation is a global producer and supplier of chemical products, serving markets across the United States, Europe, and internationally. The company's operations are divided into three distinct...
Latest News
2 days ago · marketbeat.com
What Olin (OLN) Said on Its Q3 Earnings CallOlin NYSE: OLN said it expects to close its planned merger with Huntsman in the first quarter of 2027, after clearing the Hart-Scott-Rodino waiting period in the U.S. and receiving approvals in several other jurisdictions. Regulatory reviews remain underway in Europe, China and other regions.
2 days ago · seekingalpha.com
Olin Corporation (OLN) Q3 2026 Earnings Call TranscriptOlin Corporation ( OLN ) Q3 2026 Earnings Call October 30, 2026 10:00 AM EDT Company Participants Steve Keenan - Director of Investor Relations Kenneth Lane - President, CEO & Director Todd Slater - Senior VP & CFO Conference Call Participants Frank Mitsch - Fermium Research, LLC Joshua Spector - UBS Investment Bank, Research Division Hassan Ahmed - Alembic Global Advisors Aleksey Yefremov - Barclays Bank PLC, Research Division Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division Salvator Tiano - KeyBanc Capital Markets Inc., Research Division Patrick Cunningham - Citigroup Inc., Research Division Kevin McCarthy - Vertical Research Partners, LLC Abigail Eberts - Wells Fargo Securities, LLC, Research Division Matthew DeYoe - BofA Securities, Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Matthew Blair - TPH Research Arun Viswanathan - RBC Capital Markets, Research Division Alek Ledvina - Truist Securities, Inc., Research Division David Begleiter - Deutsche Bank AG, Research Division Presentation Operator Good morning, and welcome to Olin Corporation's Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
3 days ago · zacks.com
Compared to Estimates, Olin (OLN) Q3 Earnings: A Look at Key MetricsThe headline numbers for Olin (OLN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
3 days ago · zacks.com
Olin (OLN) Q3 Earnings Beat EstimatesOlin (OLN) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.4 per share a year ago.
3 days ago · prnewswire.com
Olin Announces Third Quarter 2026 ResultsHighlights Third quarter 2026 net income of $14.4 million, or $0.13 per diluted share Quarterly adjusted EBITDA of $191.4 million Expect Olin and Huntsman merger to close first quarter 2027 Substantial progress made with integration planning CLAYTON, Mo., Oct. 29, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced financial results for the third quarter ended September 30, 2026.
28 days ago · prnewswire.com
Olin Corporation Third Quarter 2026 Earnings Conference Call AnnouncementCLAYTON, Mo., Oct. 5, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, October 30, 2026, at 10:00 a.m.
1 month ago · fool.com
Olin Just Won a $788 Million Army Contract. Is Olin Stock a Buy?The U.S. Army just awarded Olin $788.4 million to supply it with small-arms ammunition. The contract runs through September 2031.
2 months ago · zacks.com
Olin, Huntsman Merger of Equals Clears U.S. Antitrust HurdleOlin's proposed merger clears a key U.S. antitrust hurdle, with over $400M in expected synergies and a first-half 2027 closing target.
2 months ago · zacks.com
Here's Why You Should Retain Olin Stock in Your PortfolioOLN's cost cuts and planned Huntsman merger could boost earnings, while weak demand, leverage and cash flow remain key headwinds.
2 months ago · zacks.com
OLN-HUN's All-Stock Merger of Equals Approved by ShareholdersOlin and Huntsman's shareholders overwhelmingly back their all-stock merger, advancing a $12.5 billion chemicals combination targeting more than $400 million in benefits.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove OLN